New York, New York–(Newsfile Corp. – August 11, 2023) – WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) between January 28, 2021 and July 28, 2023, both…Read More
ROSEN A TOP RANKED LAW FIRM Encourages Apellis Pharmaceuticals Inc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action APLS
